154 related articles for article (PubMed ID: 21531819)
81. Comprehensive Cancer Genomic Profiling of Liver Metastasis Led to the Unexpected Identification of Colorectal Cancer.
Miyamoto H; Kawakami F; Abe S; Sugita H; Matsui H
Intern Med; 2024 Jan; 63(1):63-70. PubMed ID: 37164664
[TBL] [Abstract][Full Text] [Related]
82. ASO Author Reflections: Characterizing the Impact of RAS Mutation Location on Outcomes for Colorectal Liver Metastases.
Saadat LV; D'Angelica MI
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):867-868. PubMed ID: 32725531
[No Abstract] [Full Text] [Related]
83. The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins.
Poeta ML; Manola J; Goldenberg D; Forastiere A; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM
Clin Cancer Res; 2009 Dec; 15(24):7658-7665. PubMed ID: 19996217
[TBL] [Abstract][Full Text] [Related]
84. Detection of circulating tumor DNA in early- and late-stage human malignancies.
Bettegowda C; Sausen M; Leary RJ; Kinde I; Wang Y; Agrawal N; Bartlett BR; Wang H; Luber B; Alani RM; Antonarakis ES; Azad NS; Bardelli A; Brem H; Cameron JL; Lee CC; Fecher LA; Gallia GL; Gibbs P; Le D; Giuntoli RL; Goggins M; Hogarty MD; Holdhoff M; Hong SM; Jiao Y; Juhl HH; Kim JJ; Siravegna G; Laheru DA; Lauricella C; Lim M; Lipson EJ; Marie SK; Netto GJ; Oliner KS; Olivi A; Olsson L; Riggins GJ; Sartore-Bianchi A; Schmidt K; Shih lM; Oba-Shinjo SM; Siena S; Theodorescu D; Tie J; Harkins TT; Veronese S; Wang TL; Weingart JD; Wolfgang CL; Wood LD; Xing D; Hruban RH; Wu J; Allen PJ; Schmidt CM; Choti MA; Velculescu VE; Kinzler KW; Vogelstein B; Papadopoulos N; Diaz LA
Sci Transl Med; 2014 Feb; 6(224):224ra24. PubMed ID: 24553385
[TBL] [Abstract][Full Text] [Related]
85. Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood.
Higgins MJ; Jelovac D; Barnathan E; Blair B; Slater S; Powers P; Zorzi J; Jeter SC; Oliver GR; Fetting J; Emens L; Riley C; Stearns V; Diehl F; Angenendt P; Huang P; Cope L; Argani P; Murphy KM; Bachman KE; Greshock J; Wolff AC; Park BH
Clin Cancer Res; 2012 Jun; 18(12):3462-9. PubMed ID: 22421194
[TBL] [Abstract][Full Text] [Related]
86. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.
Diaz LA; Williams RT; Wu J; Kinde I; Hecht JR; Berlin J; Allen B; Bozic I; Reiter JG; Nowak MA; Kinzler KW; Oliner KS; Vogelstein B
Nature; 2012 Jun; 486(7404):537-40. PubMed ID: 22722843
[TBL] [Abstract][Full Text] [Related]
87. BEAMing up personalized medicine: mutation detection in blood.
Richardson AL; Iglehart JD
Clin Cancer Res; 2012 Jun; 18(12):3209-11. PubMed ID: 22550168
[TBL] [Abstract][Full Text] [Related]
88. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing.
Leary RJ; Sausen M; Kinde I; Papadopoulos N; Carpten JD; Craig D; O'Shaughnessy J; Kinzler KW; Parmigiani G; Vogelstein B; Diaz LA; Velculescu VE
Sci Transl Med; 2012 Nov; 4(162):162ra154. PubMed ID: 23197571
[TBL] [Abstract][Full Text] [Related]
89. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.
Benesova L; Belsanova B; Suchanek S; Kopeckova M; Minarikova P; Lipska L; Levy M; Visokai V; Zavoral M; Minarik M
Anal Biochem; 2013 Feb; 433(2):227-34. PubMed ID: 22750103
[TBL] [Abstract][Full Text] [Related]
90. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.
Tomasetti C; Vogelstein B
Science; 2015 Jan; 347(6217):78-81. PubMed ID: 25554788
[TBL] [Abstract][Full Text] [Related]
91. Only three driver gene mutations are required for the development of lung and colorectal cancers.
Tomasetti C; Marchionni L; Nowak MA; Parmigiani G; Vogelstein B
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):118-23. PubMed ID: 25535351
[TBL] [Abstract][Full Text] [Related]
92. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles.
Chen WW; Balaj L; Liau LM; Samuels ML; Kotsopoulos SK; Maguire CA; Loguidice L; Soto H; Garrett M; Zhu LD; Sivaraman S; Chen C; Wong ET; Carter BS; Hochberg FH; Breakefield XO; Skog J
Mol Ther Nucleic Acids; 2013 Jul; 2(7):e109. PubMed ID: 23881452
[TBL] [Abstract][Full Text] [Related]
93. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas.
Taniguchi K; Uchida J; Nishino K; Kumagai T; Okuyama T; Okami J; Higashiyama M; Kodama K; Imamura F; Kato K
Clin Cancer Res; 2011 Dec; 17(24):7808-15. PubMed ID: 21976538
[TBL] [Abstract][Full Text] [Related]
94. Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer.
Spindler KL; Pallisgaard N; Andersen RF; Brandslund I; Jakobsen A
PLoS One; 2015; 10(4):e0108247. PubMed ID: 25875772
[TBL] [Abstract][Full Text] [Related]
95. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
Mostert B; Sieuwerts AM; Bolt-de Vries J; Kraan J; Lalmahomed Z; van Galen A; van der Spoel P; de Weerd V; Ramírez-Moreno R; Smid M; Verhoef C; IJzermans JN; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Mol Oncol; 2015 Apr; 9(4):920-32. PubMed ID: 25655581
[TBL] [Abstract][Full Text] [Related]
96. Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?
Ilie M; Hofman V; Long E; Bordone O; Selva E; Washetine K; Marquette CH; Hofman P
Ann Transl Med; 2014 Nov; 2(11):107. PubMed ID: 25489581
[TBL] [Abstract][Full Text] [Related]
97. Tracking tumor resistance using 'liquid biopsies'.
Pantel K; Diaz LA; Polyak K
Nat Med; 2013 Jun; 19(6):676-7. PubMed ID: 23744147
[No Abstract] [Full Text] [Related]
98. Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.
Heitzer E; Auer M; Hoffmann EM; Pichler M; Gasch C; Ulz P; Lax S; Waldispuehl-Geigl J; Mauermann O; Mohan S; Pristauz G; Lackner C; Höfler G; Eisner F; Petru E; Sill H; Samonigg H; Pantel K; Riethdorf S; Bauernhofer T; Geigl JB; Speicher MR
Int J Cancer; 2013 Jul; 133(2):346-56. PubMed ID: 23319339
[TBL] [Abstract][Full Text] [Related]
99. BEAMing sheds light on drug resistance.
Lauring J; Park BH
Clin Cancer Res; 2011 Dec; 17(24):7508-10. PubMed ID: 22065078
[TBL] [Abstract][Full Text] [Related]
100. Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.
Zavarykina TM; Lomskova PK; Pronina IV; Khokhlova SV; Stenina MB; Sukhikh GT
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
